CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs

FASEB Journal

Volumn 24, Issue 3, 2010, Pages 712-722

  Thorgersen, Ebbe Billmann ^a   Hellerud, Bernt Christian ^a   Nielsen, Erik Waage ^b,c   Barratt Due, Andreas ^a   Fure, Hilde ^b   Lindstad, Julie Katrine ^a   Pharo, Anne ^a   Fosse, Erik ^a   Tønnessen, Tor Inge ^a   Johansen, Harald Thidemann ^d   Castellheim, Albert ^a   Mollnes, Tom Eirik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORDLAND HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Gram negative bacteria; Inflammation; Innate immunity; Lipopolysaccharide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD11B ANTIGEN; CD14 ANTIGEN; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BLOOD CLOTTING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DETERMINATION; ESCHERICHIA COLI; FEMALE; FIBRINOLYSIS; FLOW CYTOMETRY; GRAM NEGATIVE SEPSIS; HEMODYNAMICS; HEMOSTASIS; IMMUNOFLUORESCENCE; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; CHEMICALLY INDUCED DISORDER; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SEPSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; SUIDAE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; SEPSIS; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952296285     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-140798     Document Type: Article

References (59)

1. Sriskandan, S., and Altmann, D. M. (2008) The immunology of sepsis. J. Pathol. 214, 211-223
2. Levi, M., and Opal, S. M. (2006) Coagulation abnormalities in critically ill patients. Crit. Care 10, 222 (Pubitemid 47086933)
3. Annane, D., Bellissant, E., and Cavaillon, J. M. (2005) Septic shock. Lancet 365, 63-78
4. Martin, G. S., Mannino, D. M., Eaton, S., and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554 (Pubitemid 36437931)
5. Bianchi, M. E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5
6. Janeway, C. A., Jr. (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11-16
7. Matzinger, P. (2002) The danger model: a renewed sense of self. Science 296, 301-305
8. Medzhitov, R. (2008) Origin and physiological roles of inflammation. Nature 454, 428-435
9. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van, H. C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (Pubitemid 29001265)
10. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., and Gusovsky, F. (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692 (Pubitemid 129528264)
11. Tang, A. H., Brunn, G. J., Cascalho, M., and Platt, J. L. (2007) Pivotal advance: Endogenous pathway to SIRS, sepsis, and related conditions. J. Leukoc. Biol. 82, 282-285
12. Roger, T., Froidevaux, C., Le, R. D., Reymond, M. K., Chanson, A. L., Mauri, D., Burns, K., Riederer, B. M., Akira, S., and Calandra, T. (2009) Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A. 106, 2348-2352
13. Akira, S., Uematsu, S., and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801
14. Miyake, K. (2006) Roles for accessory molecules in microbial recognition by Toll-like receptors. J. Endotoxin Res. 12, 195-204
15. Akashi-Takamura, S., and Miyake, K. (2008) TLR accessory molecules. Curr. Opin. Immunol. 20, 420-425
16. Goldfarb, R. D., Dellinger, R. P., and Parrillo, J. E. (2005) Porcine models of severe sepsis: emphasis on porcine peritonitis. Shock 24(Suppl. 1), 75-81
17. Michie, H. R. (1998) The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J. Antimicrob. Chemother. 41(Suppl. A), 47-49
18. Castellheim, A., Thorgersen, E. B., Hellerud, B. C., Pharo, A., Johansen, H. T., Brosstad, F., Gaustad, P., Brun, H., Fosse, E., Tonnessen, T. I., Nielsen, E. W., and Mollnes, T. E. (2008) New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs. Scand. J. Immunol. 68, 75-84
19. Barboni, B., Turriani, M., Galeati, G., Spinaci, M., Bacci, M. L., Forni, M., and Mattioli, M. (2000) Vascular endothelial growth factor production in growing pig antral follicles. Biol. Reprod. 63, 858-864
20. Heussen, C., and Dowdle, E. B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196-202
21. Makowski, G. S., and Ramsby, M. L. (1996) Calibrating gelatin zymograms with human gelatinase standards. Anal. Biochem. 236, 353-356
22. Saetre, T., Lindgaard, A. K., and Lyberg, T. (2000) Systemic activation of coagulation and fibrinolysis in a porcine model of serogroup A streptococcal shock. Blood Coagul. Fibrinolysis 11, 433-438
23. Ulevitch, R. J. (2001) New therapeutic targets revealed through investigations of innate immunity. Crit. Care Med. 29, S8-12
24. Leturcq, D. J., Moriarty, A. M., Talbott, G., Winn, R. K., Martin, T. R., and Ulevitch, R. J. (1996) Antibodies against CD14 protect primates from endotoxin-induced shock. J. Clin. Invest. 98, 1533-1538 (Pubitemid 26327861)
25. Verbon, A., Dekkers, P. E., ten Hove, T., Hack, C. E., Pribble, J. P., Turner, T., Souza, S., Axtelle, T., Hoek, F. J., van Deventer, S. J., and van der Poll, T. (2001) IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J. Immunol. 166, 3599-3605
26. Schimke, J., Mathison, J., Morgiewicz, J., and Ulevitch, R. J. (1998) Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc. Natl. Acad. Sci. U. S. A. 95, 13875-13880 (Pubitemid 28523066)
27. Olszyna, D. P., Verbon, A., Pribble, J. P., Turner, T., Axtelle, T., van Deventer, S. J., and van der Poll, T. (2003) Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia. Eur. Cytokine Netw. 14, 158-162 (Pubitemid 37249235)
28. Verbon, A., Meijers, J. C., Spek, C. A., Hack, C. E., Pribble, J. P., Turner, T., Dekkers, P. E., Axtelle, T., Levi, M., van Deventer, S. J., Reitsma, P. H., and van der Poll, T. (2003) Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans. J. Infect. Dis. 187, 55-61
29. Thorgersen, E. B., Pharo, A., Haverson, K., Axelsen, A. K., Gaustad, P., Kotwal, G. J., Sfyroera, G., and Mollnes, T. E. (2008) Complement- and CD14-inhibition attenuate Escherichia coli-induced inflammatory response in porcine whole blood. Infect. Immun. 77, 725-732
30. Waage, A., Halstensen, A., and Espevik, T. (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1, 355-357 (Pubitemid 17010024)
31. Patel, R. T., Deen, K. I., Youngs, D., Warwick, J., and Keighley, M. R. (1994) Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br. J. Surg. 81, 1306-1308 (Pubitemid 24275149)
32. Oberholzer, A., Souza, S. M., Tschoeke, S. K., Oberholzer, C., Abouhamze, A., Pribble, J. P., and Moldawer, L. L. (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23, 488-493
33. Marshall, J. C. (2003) Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat. Rev. Drug Discov. 2, 391-405
34. Panacek, E. A., Marshall, J. C., Albertson, T. E., Johnson, D. H., Johnson, S., MacArthur, R. D., Miller, M., Barchuk, W. T., Fischkoff, S., Kaul, M., Teoh, L., Van Meter, L., Daum, L., Lemeshow, S., Hicklin, G., and Doig, C. (2004) Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care Med. 32, 2173-2182
35. Van Deventer, S. J., Buller, H. R., ten Cate, J. W., Aarden, L. A., Hack, C. E., and Sturk, A. (1990) Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76, 2520-2526
36. Wang, E., Simard, M., Ouellet, N., Bergeron, Y., Beauchamp, D., and Bergeron, M. G. (2000) Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. J. Infect. Dis. 182, 1255-1259
37. Rahimi, A. A., Gee, K., Mishra, S., Lim, W., and Kumar, A. (2005) STAT-1 mediates the stimulatory effect of IL-10 on CD14 expression in human monocytic cells. J. Immunol. 174, 7823-7832 (Pubitemid 40806291)
38. Sandanger, O., Ryan, L., Bohnhorst, J., Iversen, A. C., Husebye, H., Halaas, O., Landro, L., Aukrust, P., Froland, S. S., Elson, G., Visintin, A., Oktedalen, O., Damas, J. K., Sundan, A., Golenbock, D., and Espevik, T. (2009) IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients. J. Immunol. 182, 588-595
39. Mollnes, T. E., Brekke, O. L., Fung, M., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegård, K. T., Köhl, J., and Lambris, J. D. (2002) Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100, 1869-1877 (Pubitemid 34925168)
40. Van Furth, A. M., Verhard-Seijmonsbergen, E. M., Langermans, J. A., van Dissel, J. T., and van Furth, R. (1999) Anti-CD14 monoclonal antibodies inhibit the production of tumor necrosis factor α and interleukin-10 by human monocytes stimulated with killed and live Haemophilus influenzae or Streptococcus pneumoniae organisms. Infect. Immun. 67, 3714-3718
41. Adib-Conquy, M., Moine, P., Asehnoune, K., Edouard, A., Espevik, T., Miyake, K., Werts, C., and Cavaillon, J. M. (2003) Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am. J. Respir. Crit. Care Med. 168, 158-164 (Pubitemid 36920968)
42. Stephens, D. S., Greenwood, B., and Brandtzaeg, P. (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369, 2196-2210
43. Leibovici, L., Drucker, M., Samra, Z., Konisberger, H., and Pitlik, S. D. (1995) Prognostic significance of the neutrophil count in immunocompetent patients with bacteremia. Q. J. Med. 88, 181-189
44. Cavaillon, J. M., Adrie, C., Fitting, C., and Adib-Conquy, M. (2005) Reprogramming of circulatory cells in sepsis and SIRS. J. Endotoxin Res. 11, 311-320 (Pubitemid 41556040)
45. Masure, S., Proost, P., Van Damme, J., and Opdenakker, G. (1991) Purification and identification of 91-kDa neutrophil gelatinase: release by the activating peptide interleukin-8. Eur. J. Biochem. 198, 391-398
46. Opdenakker, G., Van den Steen, P. E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., and Van Damme, J. (2001) Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69, 851-859 (Pubitemid 32577883)
47. Dubois, B., Starckx, S., Pagenstecher, A., Oord, J., Arnold, B., and Opdenakker, G. (2002) Gelatinase B deficiency protects against endotoxin shock. Eur. J. Immunol. 32, 2163-2171 (Pubitemid 34965879)
48. Renckens, R., Roelofs, J. J., Florquin, S., de Vos, A. F., Lijnen, H. R., Van't, V. C., and van der Poll, T. (2006) Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J. Immunol. 176, 3735-3741
49. Hu, J., Van den Steen, P. E., Dillen, C., and Opdenakker, G. (2005) Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. Biochem. Pharmacol. 70, 535-544 (Pubitemid 40978543)
50. Brekke, O. L., Christiansen, D., Fure, H., Fung, M., and Mollnes, T. E. (2007) The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J. Leukoc. Biol. 81, 1404-1413
51. Triantafilou, M., Brandenburg, K., Kusumoto, S., Fukase, K., Mackie, A., Seydel, U., and Triantafilou, K. (2004) Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem. J. 381, 527-536
52. Levi, M., and Ten, C. H. (1999) Disseminated intravascular coagulation. N. Engl. J. Med. 341, 586-592
53. Kutzsche, S., Schlichting, E., Aspelin, T., and Lyberg, T. (2000) Hemodynamic changes and systemic activation of coagulation and fibrinolysis during controlled endotoxemia in pigs. Thromb. Res. 98, 517-529
54. Zeerleder, S., Schroeder, V., Hack, C. E., Kohler, H. P., and Wuillemin, W. A. (2006) TAFI and PAI-1 levels in human sepsis. Thromb. Res. 118, 205-212
55. Levi, M., van der Poll, T., ten Cate, H., and van Deventer, S. J. (1997) The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur. J. Clin. Invest. 27, 3-9
56. Frevert, C. W., Matute-Bello, G., Skerrett, S. J., Goodman, R. B., Kajikawa, O., Sittipunt, C., and Martin, T. R. (2000) Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J. Immunol. 164, 5439-5445 (Pubitemid 30305227)
57. Opal, S. M., Palardy, J. E., Parejo, N., and Jasman, R. L. (2003) Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Crit. Care Med. 31, 929-932
58. Marshall, J. C. (2008) Sepsis: rethinking the approach to clinical research. J. Leukoc. Biol. 83, 471-482
59. Mollnes, T. E., Christiansen, D., Brekke, O. L., and Espevik, T. (2008) Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Adv. Exp. Med. Biol. 632, 253-263